Evidence map›Paper›PMID 30695113›Full record

ArticleCancer2019

Factors influencing prostate cancer treatment decisions for African American and white men.

Brittaney-Belle E Gordon, Ramsankar Basak, William R Carpenter, Deborah Usinger, Paul A Godley, Ronald C Chen

Abstract readComparative Study
In one paragraph

Article in Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Brittaney-Belle E GordonUniversity of North Carolina School of Medicine, Chapel Hill, North Carolina.
Ramsankar BasakDepartment of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
William R CarpenterUniversity of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
Deborah UsingerUniversity of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
Paul A GodleyUniversity of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
Ronald C ChenUniversity of North Carolina School of Medicine, Chapel Hill, North Carolina.

Funding

Patient-Centered Outcomes Research Institute CER-1310-06453
6 · The paper itself

Abstract

backgroundProstate cancer racial disparities in mortality outcomes are the largest in all of oncology, and less aggressive treatment received by African American (AA) patients versus white patients is likely a contributing factor. However, the reasons underlying the differences in treatment are unclear.

methodsThis study examined a prospective, population-based cohort of 1170 men with newly diagnosed nonmetastatic prostate cancer enrolled from 2011 to 2013 before treatment throughout North Carolina. By phone survey, each participant was asked to rate the aggressiveness of his cancer, and his response was compared to the actual diagnosis based on a medical record review. Participants were also asked to rate the importance of 10 factors for their treatment decision-making process.

resultsAmong AA and white patients with low-risk cancer (according to National Comprehensive Cancer Network guidelines), 78% to 80% perceived their cancers to be "not very aggressive." However, among high-risk patients, 54% of AA patients considered their cancers to be "not very aggressive," whereas 24% of white patients did (P < .001). Although both AA and white patients indicated that a cure was a very important decision-making factor, AAs were significantly more likely to consider cost, treatment time, and recovery time as very important. In a multivariable analysis, perceived cancer aggressiveness and cure as the most important factor were significantly associated with receiving any aggressive treatment and were associated with surgery (vs radiation). After adjustments for these factors and sociodemographic factors, race was not significantly associated with the treatment received.

conclusionsRacial differences in perceived cancer aggressiveness and factors important in treatment decision making provide novel insights into reasons for the known racial disparities in prostate cancer as well as potential targets for interventions to reduce these disparities.

Indexed as

Clinical Decision-MakingEarly Detection of CancerAgedBlack or African AmericanCohort StudiesDatabases, FactualHealthcare DisparitiesHumansLogistic ModelsMaleMiddle AgedMultivariate AnalysisNeoplasm InvasivenessNeoplasm StagingNorth CarolinaProstatic Neoplasmsclinical decision makinghealth care disparitiesminority healthprostatic neoplasmstreatment outcomes

Identifiers

PMID30695113
PMCPMC6604809

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.